About
3.75USD+0.08 +2.18%
Closed • Updated at 13:14 GMT+00:00Market Cap$298.67M
P/E Ratio17.18
Volume812.3K
Beta1.10
RSI33.16
Gross Margin64.28%
Niagen Bioscience, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 8 2026
Niagen Bioscience Announces Participation in Upcoming Investor Conferences
May 6 2026
Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results
May 4 2026
Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit Offering
Apr 28 2026
Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™
Apr 22 2026
Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
Google Übersetzer